Transcription factors WT1 and p53 combined: a prognostic biomarker in ovarian cancer

BACKGROUND: New approaches to ovarian cancer are needed to improve survival. Wilms’ tumour 1 (WT1) is a tumour-associated antigen expressed in many ovarian cancers. P53 is also often altered. The clinical significance of the combined expression of these two transcription factors has not been studied...

Descripción completa

Detalles Bibliográficos
Autores principales: Carter, Julia H., Deddens, James A., Mueller, Gretchen, Lewis, Thomas G., Dooley, Mariah K., Robillard, Michelle C., Frydl, Molly, Duvall, Lydia, Pemberton, Jackson O., Douglass, Larry E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134086/
https://www.ncbi.nlm.nih.gov/pubmed/30057405
http://dx.doi.org/10.1038/s41416-018-0191-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134086/
https://www.ncbi.nlm.nih.gov/pubmed/30057405
http://dx.doi.org/10.1038/s41416-018-0191-x

Ejemplares similares